glp 1 cardiovascular effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients The Many Cardiovascular Benefits of

Your initial physician-guided consultation is $79

Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, Christensen MB, Vilsbll T, Holst JJ, Rosenkilde MM, Knop FK

All of this is why demand for GLP-1s has increased exponentially in the past few years

While these findings provide preliminary evidence of the potential benefit of semaglutide in CUD in real-world populations further preclinical studies are warranted to understand the underlying mechanism and randomized clinical trials are needed to support its use clinically for CUD

It meets people where they are, adapts as their needs change, and helps them build a healthier relationship with food, movement, and their bodies

Agree that this likely signals the beginning of a broader small-molecule GLP-1 era